Although the penetrance of MTC and PHEO is similar to that of MEN2A, PHPT will not be present in this subgroup of patients; instead, they will exhibit a diversity of extra-endocrine symptoms [41]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.